Our journey began as a research project at the Singapore University of Technology and Design, where we initially explored ideas for a modern alternative to orthopaedic casting
A year later in 2022, we launched our first minimum viable product with an in-house 4D-printing concept and partnered with local healthcare institutions. In September, we officially incorporated and became a spin-off from the university
The following year, our products underwent regulatory approvals as we began small-scale production for pilot testing with our own custom-built additive manufacturing machines
In 2024, we brought our first product to multiple markets. Today, we face rapidly increasing demand worldwide, and look to scale across the globe over the next 2 years
If you share our vision, join us in amplifying our positive impact across the field
